Letter to the shareholders

We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial, read more


Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec